Gliclazide and Metastases to peritoneum - a phase IV clinical study of FDA data

Summary:

Metastases to peritoneum is found among people who take Gliclazide, especially for people who are male, 60+ old, have been taking the drug for 6 - 12 months.

The phase IV clinical study analyzes which people take Gliclazide and have Metastases to peritoneum. It is created by eHealthMe based on reports of 22,504 people who have side effects when taking Gliclazide from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 04, 2022

22,504 people reported to have side effects when taking Gliclazide.
Among them, 17 people (0.08%) have Metastases to peritoneum.


What is Gliclazide?

Gliclazide has active ingredients of gliclazide. It is often used in diabetes. eHealthMe is studying from 22,713 Gliclazide users for its effectiveness, alternative drugs and more.

What is Metastases to peritoneum?

Metastases to peritoneum (cancer spreads to peritoneum) is found to be associated with 573 drugs and 311 conditions by eHealthMe.

Number of Gliclazide and Metastases to peritoneum reports submitted per year:

Could Gliclazide cause Metastases to peritoneum?

Time on Gliclazide when people have Metastases to peritoneum *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 100 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Metastases to peritoneum when taking Gliclazide *:

  • female: 47.06 %
  • male: 52.94 %

Age of people who have Metastases to peritoneum when taking Gliclazide *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common drugs people take besides Gliclazide *:

  1. Janumet: 8 people, 47.06%
  2. Bisoprolol Fumarate: 7 people, 41.18%
  3. Diltiazem Hydrochloride: 7 people, 41.18%
  4. Fosinopril Sodium And Hydrochlorothiazide: 7 people, 41.18%
  5. Digoxin: 6 people, 35.29%
  6. Warfarin Sodium: 4 people, 23.53%
  7. Mometasone Furoate: 4 people, 23.53%
  8. Aspirin: 4 people, 23.53%
  9. Bisacodyl: 4 people, 23.53%
  10. Clonazepam: 4 people, 23.53%

Common side effects people have besides Metastases to peritoneum *:

  1. Weight Decreased: 11 people, 64.71%
  2. Cardiac Failure: 8 people, 47.06%
  3. Anuria (failure of the kidneys to produce urine): 8 people, 47.06%
  4. Hypoglycemia (low blood sugar): 8 people, 47.06%
  5. Colon Cancer: 7 people, 41.18%
  6. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 7 people, 41.18%
  7. Metastases To Liver (cancer spreads to liver): 5 people, 29.41%
  8. Metastases To Lung (cancer spreads to lung): 4 people, 23.53%
  9. Metastasis (spreadable cancer to other organ from origin): 4 people, 23.53%
  10. Metastases To Pelvis (cancer spreads to pelvis): 3 people, 17.65%

Common conditions people have *:

  1. High Blood Pressure: 10 people, 58.82%
  2. Arrhythmias (irregular heartbeat): 7 people, 41.18%
  3. Metastases To Lung (cancer spreads to lung): 3 people, 17.65%
  4. Metastases To Liver (cancer spreads to liver): 3 people, 17.65%
  5. Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 3 people, 17.65%
  6. Transient Ischaemic Attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)): 1 person, 5.88%
  7. Psoriasis (immune-mediated disease that affects the skin): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Gliclazide and have Metastases to peritoneum?

Check whether Metastases to peritoneum is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Metastases to peritoneum and when was it recovered:

Expand to all the drugs that have ingredients of gliclazide:

Alternative drugs to, pros and cons of Gliclazide:

Common Gliclazide side effects:

Browse all side effects of Gliclazide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Metastases to peritoneum treatments and more:

COVID vaccines that are related to Metastases to peritoneum:

Common drugs associated with Metastases to peritoneum:

All the drugs that are associated with Metastases to peritoneum:

Common conditions associated with Metastases to peritoneum:

All the conditions that are associated with Metastases to peritoneum:

How the study uses the data?

The study uses data from the FDA. It is based on gliclazide (the active ingredients of Gliclazide) and Gliclazide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: